How have VAL shares performed in 2024?

ValiRx's stock was trading at GBX 5.90 at the start of the year. Since then, VAL shares have decreased by 42.0% and is now trading at GBX 3.42. View the best growth stocks for 2024 here .

How were ValiRx's earnings last quarter?

ValiRx plc (LON:VAL) posted its earnings results on Monday, September, 7th. The company reported ($4.43) earnings per share (EPS) for the quarter.

What other stocks do shareholders of ValiRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ValiRx investors own include Petrofac (PFC) , boohoo group (BOO) , ReNeuron Group (RENE) , Falanx Group (FLX) , Scirocco Energy Plc (SOLO.L) (SOLO) , CyanConnode (CYAN) , IQE (IQE) , Lloyds Banking Group (LLOY) , Eckoh (ECK) and Sareum (SAR) .

How do I buy shares of ValiRx?

Shares of VAL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:VAL

ValiRx (VAL) Share Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free VAL Stock Alerts

GBX 3.40

-0.23 (-6.21%)

(As of 06:56 AM ET)

Compare

Today's Range: 3.40
▼
3.63
50-Day Range: 3.42
▼
4.90
52-Week Range: 3.40
▼
15

Volume: 223,641 shs
Average Volume: 720,527 shs
Market Capitalization: £4.50 million

P/E Ratio: N/A
Dividend Yield: 0.63%
Price Target: N/A

Stock Analysis Chart Competitors Headlines

Get ValiRx alerts:

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About ValiRx Stock (LON:VAL)

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer. Its drug candidates also comprise VAL301, a peptide ingredient that in pre-clinical development for the treatment of endometriosis; and BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc was incorporated in 2000 and is based in Nuneaton, the United Kingdom.

VAL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VAL Stock News Headlines

February 28, 2024 | msn.com

New method discovered to halt active cancer cells

February 27, 2024 | uk.news.yahoo.com

Scientists discover 'two-punch' method to eliminate cancer cells

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

February 13, 2024 | lse.co.uk

ValiRx says requisition notice from shareholder group is invalid

February 9, 2024 | lse.co.uk

TRADING UPDATES: ValiRx receives shareholder request for board change

December 5, 2023 | markets.businessinsider.com

European Stocks Close Mostly Higher

December 5, 2023 | markets.businessinsider.com

European Markets Move Mostly Higher

December 5, 2023 | lse.co.uk

ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

November 15, 2023 | morningstar.com

ValiRx PLC EAJF

November 10, 2023 | lse.co.uk

ValiRx signs deal to evaluate StingRay Bio drug candidates

October 6, 2023 | lse.co.uk

CORRECT (Oct 5): ICG Enterprise ups interim payout on better results

October 6, 2023 | lse.co.uk

ValiRx sees no reason for shares jump; notes TheoremRx mulls merger

September 11, 2023 | finance.yahoo.com

VAL.L - ValiRx plc

August 24, 2023 | lse.co.uk

ValiRx interim loss widens as costs increase; hails Inaphaea progress

August 24, 2023 | marketwatch.com

ValiRx Shares Rise on Higher Income Expectations From Inaphaea BioLabs

August 14, 2023 | lse.co.uk

ValiRx signs collaborative services agreement with Agility

August 14, 2023 | marketwatch.com

ValiRx Shares Rise After Collaborative Services Agreement With Agility

July 19, 2023 | marketwatch.com

ValiRx Shares Rise After Subsidiary Secures Contract

June 28, 2023 | lse.co.uk

TRADING UPDATES: All Things Considered raises funds to buy Sandbag

June 16, 2023 | lse.co.uk

ValiRx shares drop after cancer drug research dropped

June 16, 2023 | marketwatch.com

ValiRx Shares Fall After Cancer-Drug Development Abandoned

June 8, 2023 | marketwatch.com

ValiRx Changes IP Exclusivity Terms With TheoremRx to Exclude Greater China

June 7, 2023 | lse.co.uk

ValiRx expands cancer research agreement with University of Barcelona

June 3, 2023 | lse.co.uk

Self Storage Gr Share Chat

May 4, 2023 | msn.com

Milner Therapeutics Institute welcomes Cathy Tralau-Stewart as executive director

March 26, 2023 | marketwatch.com

Global Endometriosis Drugs Market Research Growth, Regions, Type and Application, Forecast Analysis to 2023-2030 By VMReports

See More Headlines

Receive VAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ValiRx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/07/2020
Today: 4/17/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:VAL
CUSIP: N/A
CIK: N/A
Web: www.valirx.com
Phone: +44-20-30084416
Fax: N/A
Employees: 8
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.03)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-2,410,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -74.39%
Return on Assets: -47.22%

Debt

Debt-to-Equity Ratio: 0.73
Current Ratio: 13.37
Quick Ratio: 1.27

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: GBX 0.06 per share
Price / Cash Flow: 62.50
Book Value: GBX 4 per share
Price / Book: 0.91

Miscellaneous

Outstanding Shares: 132,350,000
Free Float: N/A
Market Cap: £4.80 million
Optionable: Not Optionable
Beta: 0.63

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Dr. Suzanne J. Dilly B.Sc. (Age 46)
BSc, Ph.D., CEO & Director
Comp: $160.85k
Mr. James Gerry Desler FCA (Age 79)
CFO, Company Secretary & Executive Director
Comp: $53k
Mr. Kumar Nawani
Head of Operations
Dr. Catherine Jane Tralau-Stewart Ph.D.
Chief Scientific Officer & Board Observer
Mr. Tarquin Edwards
Head of Investor Relations & Communications
Mr. Mark Treharne
Corporate Development Manager

Key Competitors

View All Competitors

VAL Stock Analysis - Frequently Asked Questions

How have VAL shares performed in 2024?: ValiRx's stock was trading at GBX 5.90 at the start of the year. Since then, VAL shares have decreased by 42.0% and is now trading at GBX 3.42.
View the best growth stocks for 2024 here.
How were ValiRx's earnings last quarter?: ValiRx plc (LON:VAL) posted its earnings results on Monday, September, 7th. The company reported ($4.43) earnings per share (EPS) for the quarter.
What other stocks do shareholders of ValiRx own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ValiRx investors own include Petrofac (PFC), boohoo group (BOO), ReNeuron Group (RENE), Falanx Group (FLX), Scirocco Energy Plc (SOLO.L) (SOLO), CyanConnode (CYAN), IQE (IQE), Lloyds Banking Group (LLOY), Eckoh (ECK) and Sareum (SAR).
How do I buy shares of ValiRx?: Shares of VAL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:VAL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ValiRx (VAL) Share Price, News & Analysis

About ValiRx Stock (LON:VAL)

VAL Stock Price History

VAL Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

VAL Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info